脓毒症超急性期急性肝衰竭患者白蛋白及天冬氨酸转氨酶/丙氨酸转氨酶比值的预后价值:多中心回顾性队列研究
多中心回顾性队列研究纳入2019年1月至2024年2月三家医院收治的脓毒症超急性期急性肝衰竭患者73例,住院期间存活22例、死亡51例,死亡率69.86%。死亡组入院24小时内ALB、γ-GT及人工肝治疗比例低于存活组,AST/ALT、SOFA评分、LDH及血管活性药物使用比例高于存活组,差异有统计学意义。多因素Logistic回归显示ALB(OR=0.856,95%CI 0.736-0.996,P=0.044)与AST/ALT(OR=2.018,95%CI 1.137-3.580,P=0.016)为住院死亡的独立危险因素。ROC曲线显示ALB预测住院死亡的AUC为0.760(95%CI 0.637-0.884,P<0.001),ALB≤29.05 g/L时敏感度68.2%、特异度76.5%;AST/ALT的AUC为0.764(95%CI 0.639-0.888,P<0.001),AST/ALT≥1.26时敏感度59.1%、特异度90.2%。作者认为ALB与AST/ALT可作为评估脓毒症超急性期急性肝衰竭病情严重程度及预后的临床指标。
要点
- 脓毒症超急性期急性肝衰竭患者住院死亡率69.86%(51/73例死亡,22例存活)。
- 入院24小时内ALB为住院死亡的独立危险因素:OR=0.856,95%CI 0.736-0.996,P=0.044。
- 入院24小时内AST/ALT为住院死亡的独立危险因素:OR=2.018,95%CI 1.137-3.580,P=0.016。
- ALB预测住院死亡AUC=0.760(95%CI 0.637-0.884,P<0.001),ALB≤29.05 g/L时敏感度68.2%、特异度76.5%。
- AST/ALT预测住院死亡AUC=0.764(95%CI 0.639-0.888,P<0.001),AST/ALT≥1.26时敏感度59.1%、特异度90.2%。
适用人群与场景
- 2019年1月至2024年2月收治于上海健康医学院附属周浦医院、上海市浦东新区人民医院、上海市东方医院的脓毒症超急性期急性肝衰竭患者。
诊断标准与关键阈值
- ALB预测住院死亡的ROC界值为ALB≤29.05 g/L,敏感度68.2%、特异度76.5%。
- AST/ALT预测住院死亡的ROC界值为AST/ALT≥1.26,敏感度59.1%、特异度90.2%。
研究设计与关键结果
- 多中心回顾性队列研究纳入73例脓毒症超急性期急性肝衰竭患者,住院期间存活22例、死亡51例,死亡率69.86%。
- 与存活组相比,死亡组入院24小时内ALB、γ-GT及人工肝治疗比例更低,AST/ALT、SOFA评分、LDH及血管活性药物使用比例更高,差异有统计学意义。
- 多因素Logistic回归显示ALB(OR=0.856,95%CI 0.736-0.996,P=0.044)与AST/ALT(OR=2.018,95%CI 1.137-3.580,P=0.016)为住院死亡的独立危险因素。
- ALB预测住院死亡的AUC为0.760(95%CI 0.637-0.884,P<0.001),ALB≤29.05 g/L时敏感度68.2%、特异度76.5%。
- AST/ALT预测住院死亡的AUC为0.764(95%CI 0.639-0.888,P<0.001),AST/ALT≥1.26时敏感度59.1%、特异度90.2%。
- 作者认为入院24小时内ALB水平越低、AST/ALT越高,脓毒症超急性期急性肝衰竭患者预后越差;ALB和AST/ALT可作为评估病情严重程度和预后的临床指标。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对脓毒症超急性期急性肝衰竭患者,入院24小时内检测ALB与AST/ALT有助于评估病情严重程度与住院死亡风险(作者认为)。
- 作者认为ALB与AST/ALT可作为评估脓毒症超急性期急性肝衰竭严重程度及预后的临床指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the prognostic value of albumin (ALB), aspartate aminotransferase/alanine aminotransferase ratio (AST/ALT) in patients with acute liver failure (ALF) in hyperacute phase of sepsis which provided the basis for clinical evaluation and prognostic judgment and corresponding treatment options.
METHODS: A multicenter retrospective cohort study was conducted. Patients with ALF in hyperacute phase of sepsis admitted to Zhoupu Hospital Affiliated to Shanghai Health College, Shanghai Pudong New Area People's Hospital, and Shanghai Oriental Hospital from January 2019 to February 2024 were enrolled. General data such as gender and age of the patients were collected. Lactate dehydrogenase (LDH), liver function indexes [total bilirubin (TBIL), direct bilirubin (DBIL), AST, ALT, AST/ALT, ALB, total protein (TP), globulin (GLB), ALB/GLB ratio (A/G), blood amine, γ-glutamyl transpeptidase (γ-GT)], platelet count (PLT), creatinine, activated partial thromboplastin time (APTT), severity of illness scores [acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA)], serum procalcitonin (PCT), N-terminal pro-brain natriuretic peptide (NT-proBNP), arterial blood lactic acid (Lac) within 24 hours after admission, and whether to use mechanical ventilation, whether to use vasoactive drugs, whether to use artificial liver treatment and prognosis during hospitalization also were collected. The differences of clinical data between patients with different prognosis were compared. The variables with statistically significant differences in univariate analysis were included in multivariate Logistic regression analysis to determine the independent risk factors for death of patients with ALF in hyperacute phase of sepsis during hospitalization. The receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of ALB and AST/ALT for death of patients with ALF in hyperacute phase of sepsis during hospitalization.
RESULTS: A total of 73 patients with ALF in hyperacute phase of sepsis were included, with 22 survived and 51 died during hospitalization and the mortality of 69.86%. Compared with the survival group, the patients in the death group had lower ALB, γ-GT within 24 hours after admission and proportion of artificial liver treatment, and higher AST/ALT, SOFA score, LDH and proportion of use of vasoactive drugs. The differences were statistically significant. Multivariate Logistic regression analysis showed that ALB and AST/ALT were the independent risk factors for death in patients with ALF in hyperacute phase of sepsis during hospitalization [ALB: odds ratio (OR) = 0.856, 95% confidence interval (95%CI) was 0.736-0.996, P = 0.044; AST/ALT: OR = 2.018, 95%CI was 1.137-3.580, P = 0.016]. ROC curve analysis showed that the area under the curve (AUC) of ALB for predicting in-hospital death in patients with ALF in hyperacute phase of sepsis was 0.760 (95%CI was 0.637-0.884, P < 0.001). When ALB ≤ 29.05 g/L, the sensitivity was 68.2%, and the specificity was 76.5%. The AUC of AST/ALT for predicting in-hospital death in patients with ALF in hyperacute phase of sepsis was 0.764 (95%CI was 0.639-0.888, P < 0.001). When AST/ALT ≥ 1.26, the sensitivity was 59.1%, and the specificity was 90.2%.
CONCLUSIONS: The lower the ALB level, and the higher the AST/ALT within 24 hours after admission, the worse the prognosis of patients with ALF in hyperacute phase of sepsis. ALB and AST/ALT can be used as clinical indicators to evaluate the severity and prognosis of patients with ALF in hyperacute phase of sepsis.
参考来源
- Li X, Yin Q, Zhao G, et al. [Prognostic value of albumin and aspartate aminotransferase/alanine aminotransferase ratio in patients with acute liver failure in hyperacute phase of sepsis: a multicenter retrospective cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39697014. doi:10.3760/cma.j.cn121430-20240426-00386
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。